Q1 EPS Forecast for Tenet Healthcare Increased by Analyst

Tenet Healthcare Corporation (NYSE:THC) – Zacks Research upped their Q1 2026 EPS estimates for Tenet Healthcare in a report released on Tuesday, August 5th. Zacks Research analyst R. Department now forecasts that the company will earn $3.60 per share for the quarter, up from their prior forecast of $3.48. The consensus estimate for Tenet Healthcare’s current full-year earnings is $12.24 per share.

Tenet Healthcare (NYSE:THC) last issued its earnings results on Tuesday, July 22nd. The company reported $4.02 earnings per share for the quarter, topping the consensus estimate of $2.84 by $1.18. The company had revenue of $5.27 billion during the quarter, compared to the consensus estimate of $5.16 billion. Tenet Healthcare had a net margin of 7.17% and a return on equity of 24.69%. Tenet Healthcare’s quarterly revenue was up 3.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.31 EPS.

Several other research analysts also recently weighed in on THC. Raymond James Financial restated an “outperform” rating and issued a $200.00 price target (up from $185.00) on shares of Tenet Healthcare in a research note on Wednesday, July 23rd. Baird R W lowered shares of Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Royal Bank Of Canada lifted their price target on shares of Tenet Healthcare from $183.00 to $189.00 and gave the company an “outperform” rating in a report on Wednesday, April 30th. Wolfe Research downgraded shares of Tenet Healthcare from an “outperform” rating to a “peer perform” rating in a report on Monday, July 28th. Finally, JPMorgan Chase & Co. raised their price objective on Tenet Healthcare from $190.00 to $200.00 and gave the company an “overweight” rating in a research report on Monday. Four equities research analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and an average price target of $191.56.

Tenet Healthcare Stock Performance

NYSE:THC opened at $159.42 on Wednesday. The stock has a 50-day moving average price of $167.34 and a 200 day moving average price of $146.81. The stock has a market capitalization of $14.08 billion, a P/E ratio of 10.21, a P/E/G ratio of 0.68 and a beta of 1.52. Tenet Healthcare has a 12-month low of $109.82 and a 12-month high of $185.25. The company has a current ratio of 1.71, a quick ratio of 1.63 and a debt-to-equity ratio of 2.39.

Insider Activity at Tenet Healthcare

In other Tenet Healthcare news, Director James L. Bierman sold 4,613 shares of the business’s stock in a transaction on Thursday, May 29th. The shares were sold at an average price of $170.00, for a total transaction of $784,210.00. Following the transaction, the director owned 35,271 shares in the company, valued at $5,996,070. The trade was a 11.57% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this link. Also, EVP Thomas W. Arnst sold 9,786 shares of the firm’s stock in a transaction dated Wednesday, May 21st. The stock was sold at an average price of $166.00, for a total transaction of $1,624,476.00. The disclosure for this sale can be found here. Insiders have sold a total of 54,121 shares of company stock worth $8,846,305 in the last ninety days. Corporate insiders own 0.81% of the company’s stock.

Institutional Investors Weigh In On Tenet Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of the business. True Wealth Design LLC grew its position in Tenet Healthcare by 238.2% in the 2nd quarter. True Wealth Design LLC now owns 257 shares of the company’s stock valued at $45,000 after acquiring an additional 181 shares during the last quarter. AE Wealth Management LLC boosted its stake in shares of Tenet Healthcare by 28.2% during the second quarter. AE Wealth Management LLC now owns 7,133 shares of the company’s stock valued at $1,255,000 after purchasing an additional 1,569 shares during the period. Savant Capital LLC increased its stake in Tenet Healthcare by 8.8% in the 2nd quarter. Savant Capital LLC now owns 13,247 shares of the company’s stock worth $2,331,000 after buying an additional 1,066 shares during the period. Advisors Preferred LLC bought a new stake in Tenet Healthcare during the 2nd quarter valued at about $954,000. Finally, Bank of Montreal Can boosted its position in Tenet Healthcare by 19.1% in the 2nd quarter. Bank of Montreal Can now owns 31,944 shares of the company’s stock valued at $5,622,000 after buying an additional 5,128 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.